243 related articles for article (PubMed ID: 22775065)
1. Evaluation of ocular manifestations and blindness in HIV/AIDS patients in a tertiary care hospital in South India.
Ganekal S; Jhanji V; Dorairaj S; Nagarajappa A
Ocul Immunol Inflamm; 2012 Oct; 20(5):336-41. PubMed ID: 22775065
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
4. The HIV RNA Levels of Plasma and Ocular Fluids in AIDS Patients with Ophthalmic Infections.
Hsu WM; Chiou SH; Chen SS; Shyong MP; Ho CK; Chen SJ; Wu CC; Kung SH; Chi CW
Ophthalmologica; 2004; 218(5):328-32. PubMed ID: 15334014
[TBL] [Abstract][Full Text] [Related]
5. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of cytomegalovirus retinitis in Tanzanians with low CD4 levels.
Nirwoth JP; Hall AB; Lewallen S
Br J Ophthalmol; 2011 Apr; 95(4):460-2. PubMed ID: 21106992
[TBL] [Abstract][Full Text] [Related]
7. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
8. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
[TBL] [Abstract][Full Text] [Related]
11. HIV-related eye disease in patients presenting to a tertiary care government hospital in Turkey.
Akçakaya AA; Sargın F; Erbil HH; Aybar A; Sadigov F; Yaylalı SA; Akçay G; Ozgüneş N
Ocul Immunol Inflamm; 2012 Jun; 20(3):158-62. PubMed ID: 22515816
[TBL] [Abstract][Full Text] [Related]
12. [Indications for eye examination of HIV patients--screening parameters for cytomegalovirus retinitis].
Gellrich MM; Lagrèze WD; Rump JA; Hansen LL
Klin Monbl Augenheilkd; 1996; 209(2-3):72-8. PubMed ID: 8992086
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
15. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N
Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic.
Heiden D; Ford N; Wilson D; Rodriguez WR; Margolis T; Janssens B; Bedelu M; Tun N; Goemaere E; Saranchuk P; Sabapathy K; Smithuis F; Luyirika E; Drew WL
PLoS Med; 2007 Dec; 4(12):e334. PubMed ID: 18052600
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in Shanghai, China.
Shi Y; Lu H; He T; Yang Y; Liu L; Zhang R; Zheng Y; Shen Y; Zhang Y; Zhang Z
BMC Infect Dis; 2011 Nov; 11():326. PubMed ID: 22115120
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era.
Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS
Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263
[TBL] [Abstract][Full Text] [Related]
19. Tuberculoid leprosy and cytomegalovirus retinitis as immune restoration disease in a patient with AIDS.
Kumar S; Ghosh MK; Sarkar S; Mallik S; Biswas PN; Saha B
Int J Infect Dis; 2012 Feb; 16(2):e146-8. PubMed ID: 22169463
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China.
Luo J; Jing D; Kozak I; Huiming Z; Siying C; Yezhen Y; Xin Q; Luosheng T; Adelman RA; Forster SH
Ophthalmic Epidemiol; 2013 Jun; 20(3):170-5. PubMed ID: 23713918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
